372 related articles for article (PubMed ID: 16637685)
1. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
Ulvatne H; Vorland LH
Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of 15-residue lactoferricin derivatives.
Strøm MB; Rekdal O; Svendsen JS
J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
[TBL] [Abstract][Full Text] [Related]
5. Expression of recombinant Arabian camel lactoferricin-related peptide in Pichia pastoris and its antimicrobial identification.
Chahardooli M; Niazi A; Aram F; Sohrabi SM
J Sci Food Agric; 2016 Jan; 96(2):569-75. PubMed ID: 25655077
[TBL] [Abstract][Full Text] [Related]
6. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
[TBL] [Abstract][Full Text] [Related]
7. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
Strøm MB; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
[TBL] [Abstract][Full Text] [Related]
8. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
Haukland HH; Vorland LH
J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
[TBL] [Abstract][Full Text] [Related]
9. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
Nguyen LT; Schibli DJ; Vogel HJ
J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
[TBL] [Abstract][Full Text] [Related]
10. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
Haug BE; Svendsen JS
J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
13. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
Lejon T; Stiberg T; Strøm MB; Svendsen JS
J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
[TBL] [Abstract][Full Text] [Related]
14. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
[TBL] [Abstract][Full Text] [Related]
16. Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.
Arias M; McDonald LJ; Haney EF; Nazmi K; Bolscher JG; Vogel HJ
Biometals; 2014 Oct; 27(5):935-48. PubMed ID: 24916114
[TBL] [Abstract][Full Text] [Related]
17. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
18. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.
Liu Y; Han F; Xie Y; Wang Y
Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695
[TBL] [Abstract][Full Text] [Related]
19. Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin.
Murata M; Wakabayashi H; Yamauchi K; Abe F
J Dairy Sci; 2013 Aug; 96(8):4891-8. PubMed ID: 23769363
[TBL] [Abstract][Full Text] [Related]
20. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).
Feng Y; Huang N; Wu Q; Bao L; Wang BY
Acta Pharmacol Sin; 2005 Sep; 26(9):1087-92. PubMed ID: 16115376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]